Dosage: Usually, take 1 tablet (5 mg) once daily. Timing: Can be taken with or without food, preferably at the same time each day to maintain consistent levels in your body. Swallow: Take the tablet whole with a glass of water. Do not crush or chew. Duration: Treatment is usually long-term—it may take 3 to 6 months or longer to notice improvement in symptoms. Missed Dose: If you miss a dose, take it as soon as you remember unless it’s near the time for your next dose. Do not double up doses. Follow-Up: Regular follow-ups with your doctor are important to monitor progress and side effects.
Blue-coloured, apple-shaped, film-coated tablets marked 'Proscar' on one side and 'MSD 72' on the other. 'Proscar' is indicated for the treatment and control of benign prostatic hyperplasia (BPH) in patients with an enlarged prostate to: ... The recommended adult dose is one 5 mg tablet daily, with or without food.
✅ Before Taking Proscar Inform your doctor if you: Are allergic to finasteride or any ingredients in the tablet. Have liver problems or any history of prostate cancer. Are a woman, especially if pregnant or planning pregnancy—Proscar is not for use in women. Are under 18 years old (not recommended for children or adolescents).
Reduces Prostate Size: By lowering DHT levels, Proscar shrinks an enlarged prostate, relieving pressure on the urethra. Improves Urinary Symptoms: Helps reduce symptoms of benign prostatic hyperplasia (BPH) such as: Difficulty starting urination Weak urine stream Frequent or urgent need to urinate Nighttime urination (nocturia) Decreases Risk of Acute Urinary Retention: Lowers the chance of sudden inability to urinate, which may require catheterization or surgery. Reduces Need for Prostate Surgery: Long-term use may help avoid or delay the need for invasive procedures to relieve BPH symptoms. Improves Quality of Life: By easing urinary difficulties, it enhances comfort, sleep quality, and daily functioning. Reduces Prostate Size: By lowering DHT levels, Proscar shrinks an enlarged prostate, relieving pressure on the urethra. Improves Urinary Symptoms: Helps reduce symptoms of benign prostatic hyperplasia (BPH) such as: Difficulty starting urination Weak urine stream Frequent or urgent need to urinate Nighttime urination (nocturia) Decreases Risk of Acute Urinary Retention: Lowers the chance of sudden inability to urinate, which may require catheterization or surgery. Reduces Need for Prostate Surgery: Long-term use may help avoid or delay the need for invasive procedures to relieve BPH symptoms. Improves Quality of Life: By easing urinary difficulties, it enhances comfort, sleep quality, and daily functioning.
Mechanism: Finasteride works by inhibiting the enzyme 5-alpha reductase, which converts testosterone into dihydrotestosterone (DHT). Lowering DHT levels reduces prostate size and helps relieve urinary symptoms associated with BPH. Onset of Action: Effects may take 3 to 6 months or longer to become noticeable. Continued use is necessary to maintain benefits. Long-Term Use: Proscar is typically prescribed for long-term management of BPH. Stopping treatment may cause symptoms to return. Not for Hair Loss: Proscar is formulated for BPH treatment. A lower-dose version (Propecia 1 mg) is used for male pattern baldness. Interactions: May interact with other medications such as hormone therapies or certain antifungals; always inform your doctor of all medicines you are taking. Monitoring: Regular follow-ups are recommended to assess prostate health and check for any side effects. Pregnancy Warning: Women who are or may become pregnant should avoid exposure to the tablets, especially if crushed or broken, as finasteride can cause birth defects in a male fetus.
Ingredient Amount per Tablet Role Active Ingredient Finasteride 5 mg 5-alpha reductase inhibitor – reduces DHT to shrink the prostate Inactive Ingredients (Excipients) Lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, hypromellose, titanium dioxide, polyethylene glycol Help form the tablet and ensure stability, appearance, and controlled release